169 related articles for article (PubMed ID: 37867588)
1. A critical appraisal of mucormycosis in COVID- 19 patients in a tertiary care centre in India.
Raychaudhuri S; Taneja J; Sasidharan J; Pujani M; Singh K; Chatterjee T; Jain M; Chandoke R; Rai A; Abbas Z; Das A
Curr Med Mycol; 2023 Mar; 9(1):1-7. PubMed ID: 37867588
[TBL] [Abstract][Full Text] [Related]
2. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
Kumar S; Kumar H; Mali M; Meena BL
Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
[TBL] [Abstract][Full Text] [Related]
3. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
4. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
5. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
[TBL] [Abstract][Full Text] [Related]
6. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of histopathological analysis, KOH wet mount and fungal culture to diagnose fungal infections in post-COVID patients.
Baxi SN; Gohil MR; Navadiya AJ; Bapodra MK; Patel HR
Indian J Pathol Microbiol; 2023; 66(3):540-544. PubMed ID: 37530335
[TBL] [Abstract][Full Text] [Related]
8. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
Yadav S; Bs N; Ak S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
[TBL] [Abstract][Full Text] [Related]
9. Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.
Fatima N; Ahmed S; Shameem M; Ahmed A; Hasan W; Khan PA
Indian J Med Microbiol; 2023; 46():100467. PubMed ID: 37651764
[TBL] [Abstract][Full Text] [Related]
10. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
[TBL] [Abstract][Full Text] [Related]
13. A Comparison Between Potassium Hydroxide (KOH) Microscopy and Culture for the Detection of Post-COVID-19 Rhino-Orbital-Cerebral Mucormycosis.
Hasan S; Gupta P; Shukla D; Banerjee G
Cureus; 2023 Oct; 15(10):e47707. PubMed ID: 38022015
[TBL] [Abstract][Full Text] [Related]
14. Role of histopathology in severity assessments of post-COVID-19 rhino-orbital cerebral mucormycosis - A case-control study.
Shanmugasundaram S; Ramasamy V; Shiguru S
Ann Diagn Pathol; 2023 Dec; 67():152183. PubMed ID: 37696132
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, Clinical Features and Management of Rhino Orbital Mucormycosis in Post COVID 19 Patients.
Desai EJ; Pandya A; Upadhya I; Patel T; Banerjee S; Jain V
Indian J Otolaryngol Head Neck Surg; 2022 Mar; 74(1):103-107. PubMed ID: 34414101
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Mucormycosis: A Black Fungus Disaster?
Chillana S; Mohit Chilana KA
Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825
[TBL] [Abstract][Full Text] [Related]
17. Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy.
Gupta S; Goyal R; Kaore NM
Indian J Otolaryngol Head Neck Surg; 2020 Mar; 72(1):104-111. PubMed ID: 32158665
[TBL] [Abstract][Full Text] [Related]
18. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
19. A retrospective clinicopathological analysis of rhino-orbital mucormycosis in second wave of COVID-19.
Thakur B; Ahuja S; Acharya S; Kaushik S
Indian J Pathol Microbiol; 2023; 66(2):411-414. PubMed ID: 37077099
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.
Raj A; Nishant P; Sadhukhan K; Saha BC; Sinha U; Kokkayil P; Gupta A; Kumar A; Tiwari P
Indian J Ophthalmol; 2023 Jan; 71(1):249-256. PubMed ID: 36588245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
